{"organizations": [], "uuid": "dc13b75c15be8a82f63f8c554ca381f7b8896684", "thread": {"social": {"gplus": {"shares": 0}, "pinterest": {"shares": 0}, "vk": {"shares": 0}, "linkedin": {"shares": 0}, "facebook": {"likes": 0, "shares": 0, "comments": 0}, "stumbledupon": {"shares": 0}}, "site_full": "www.reuters.com", "main_image": "https://s4.reutersmedia.net/resources_v2/images/rcom-default.png", "site_section": "http://feeds.reuters.com/reuters/companyNews", "section_title": "Reuters: Company News", "url": "https://www.reuters.com/article/brief-glaxosmithkline-submits-landmark-i/brief-glaxosmithkline-submits-landmark-impact-data-to-european-medicines-agency-to-support-expanded-label-for-trelegy-ellipta-idUSFWN1Q40G2", "country": "US", "domain_rank": 408, "title": "BRIEF-Glaxosmithkline Submits Landmark Impact Data To European Medicines Agency To Support Expanded Label For Trelegy Ellipta​", "performance_score": 0, "site": "reuters.com", "participants_count": 1, "title_full": "", "spam_score": 0.997, "site_type": "news", "published": "2018-02-14T17:41:00.000+02:00", "replies_count": 0, "uuid": "dc13b75c15be8a82f63f8c554ca381f7b8896684"}, "author": "Reuters Editorial", "url": "https://www.reuters.com/article/brief-glaxosmithkline-submits-landmark-i/brief-glaxosmithkline-submits-landmark-impact-data-to-european-medicines-agency-to-support-expanded-label-for-trelegy-ellipta-idUSFWN1Q40G2", "ord_in_thread": 0, "title": "BRIEF-Glaxosmithkline Submits Landmark Impact Data To European Medicines Agency To Support Expanded Label For Trelegy Ellipta​", "locations": [], "entities": {"persons": [], "locations": [], "organizations": [{"name": "glaxosmithkline plc", "sentiment": "negative"}, {"name": "reuters", "sentiment": "negative"}, {"name": "trelegy ellipta", "sentiment": "negative"}, {"name": "gsk", "sentiment": "negative"}, {"name": "eikon", "sentiment": "none"}]}, "highlightText": "", "language": "english", "persons": [], "text": "Feb 14 (Reuters) - Glaxosmithkline Plc:\n* ‍GSK SUBMITS LANDMARK IMPACT DATA TO EUROPEAN MEDICINES AGENCY TO SUPPORT EXPANDED LABEL FOR TRELEGY ELLIPTA​ Source text for Eikon: Further company coverage: (bangalore.newsroom@thomsonreuters.com)\n ", "external_links": ["http://thomsonreuters.com/en/about-us/trust-principles.html"], "published": "2018-02-14T17:41:00.000+02:00", "crawled": "2018-02-14T12:12:14.003+02:00", "highlightTitle": ""}